The Clinical Core of the Columbia University Alzheimer Disease Research Center (ADRC) provides comprehensive assessment of Alzheimer's disease (AD) and related dementia for a diverse population of individuals. In the communities of Washington Heights-Inwood and Harlem we act as a resource for the communities and physicians involved in primary care. In the tri-state are (New York, New Jersey and Connecticut) we are a resource in specialty care for patients with memory disorders. Thus, we are able to enroll patients and controls into the Clinical Core from a wide range of social and cultural backgrounds. We use standardized medical, neurological and neuropsychological assessments to elicit the functional and medical information required for the diagnosis of dementia. Our neuropsychological battery has been used for over 5,000 evaluations in our ADRC. The Core Consensus Conference reviews and establishes all diagnoses and is used to identify patients to be enrolled into various projects. The Columbia ADRC Clinical Core is responsive to current needs in AD research, providing investigators with well characterized patients with AD and controls. Our studies examine the genetic aspects of AD, clinical course and predictors of decline, quantifying and treating behavioral aspects of AD and early detection of AD and early detection of AD. With treatment of AD a priority, we have invariably met patient enrollment goals for our site in collaborative multi-center therapeutic trials. Our comprehensive and standardized database allows sharing of data with other Alzheimer's Disease Centers and local and federal agencies. In this renewed effort, we proposed to continue the previous aims by using standardized methods of evaluation to provide a well-characterized cohort of patients with AD and dementia-free controls whom we will follow annually and recruit into clinical treatment and other protocols. Working with the Pathology Core, we will obtain tissue samples to examine pathologic and genetic correlates of AD and normal aging. The Data Coordinating Center of the Clinical Core will enter and maintains all ADRC information for access for research and statistical purposes, provide biostatistical consulting to ADRC investigators, and will coordinate data-sharing with the proposed Alzheimer's Disease Data Coordinating Center (ADDCC).

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG008702-11A1
Application #
6324505
Study Section
Project Start
2000-07-01
Project End
2001-05-31
Budget Start
Budget End
Support Year
11
Fiscal Year
2000
Total Cost
$271,393
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Bravo, Francisca Vaz; Da Silva, Jorge; Chan, Robin Barry et al. (2018) Phospholipase D functional ablation has a protective effect in an Alzheimer's disease Caenorhabditis elegans model. Sci Rep 8:3540
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Grivel, Margaux M; Leong, Wei; Masucci, Michael D et al. (2018) Impact of lifetime traumatic experiences on suicidality and likelihood of conversion in a cohort of individuals at clinical high-risk for psychosis. Schizophr Res 195:549-553
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Zhou, Zilu; Wang, Weixin; Wang, Li-San et al. (2018) Integrative DNA copy number detection and genotyping from sequencing and array-based platforms. Bioinformatics 34:2349-2355
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169

Showing the most recent 10 out of 640 publications